Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.

Follmer, Cristian

Follmer, Cristian.

Follmer C; Laboratory of Biological Chemistry of Neurodegenerative Disorders, Department of Physical Chemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Mov Disord ; 35(9): 1495-1496, 2020 09.

Article in English | MEDLINE | ID: covidwho-724443

Subject(s)

COVID-19/complications; Dysbiosis/complications; Gastrointestinal Microbiome; Parkinson Disease/etiology; SARS-CoV-2/pathogenicity; Bacterial Translocation/immunology; COVID-19/microbiology; Enteric Nervous System/physiopathology; Humans; Inflammation; Lipopolysaccharides/metabolism; Lipopolysaccharides/toxicity; Microglia/immunology; Microglia/metabolism; Models, Biological; Neuroimmunomodulation; Parkinson Disease/microbiology; Protein Aggregation, Pathological; Risk Factors; Vagus Nerve/physiopathology; alpha-Synuclein/metabolism

Keywords

Parkinson's disease; coronavirus; microbiome; neuroinflammation; α-synuclein

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Dysbiosis / Gastrointestinal Microbiome / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Mov Disord Journal subject: Neurology Year: 2020 Document Type: Article Affiliation country: Mds.28231

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google